Organisational Design
Why investors must engage on the growing threat of antimicrobial resistance
Will antimicrobial resistance derail decades of medical and economic progress, or can coordinated action avert a global crisis? Anastassia Johnson, researcher at the Thinking Ahead Institute, examines the growing threat of drug-resistant infections and the role investors can play in driving sustainable solutions.
Anastassia JohnsonAugust 5, 2025